Fig. 5.
![Fig. 5. EFS according to BCL-2 expression levels in primary leukemic cells in immunophenotypically distinct patient subsets. The cumulative proportions of T-lineage ALL (shown in [A]) and B-lineage ALL (shown in [B]) patients surviving event-free are shown according to levels of BCL-2 expression on leukemic cells. Patients were divided into two groups: BCL-2 level ≥ median and BCL-2 level < median. BCL-2 level showed no prognostic effect on EFS in either subset.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/89/10/10.1182_blood.v89.10.3769/3/bl_0038f5.jpeg?Expires=1724259712&Signature=LqSHdFvhVK2QqK49xPa764OOMuQdHHd3BWlGHUjWY2Y920c9eH73kndSqn0Y5wBPkER5zHLIcNnBg4qByDZ2m16Z6pa2KZjGIvXRsTwTMER3BhM2gxtAsdhas3u222kkJSLUzkREn1HWgaH6oJEHhW3MgAYVn8ycTPi1uLjBVpwsJZZDtF69xjo~xDXGBGa~tmafTZr6wYxZ5r5Ql0jj9PUnhT1MVk4s29Oj2W7LvJ2QLDjKEcq7DkDQBW2Ur-hOXXDPTBEgaPRimpcaEZCcctkkb5omw41COooVA7VHkKd3SIV4dOhHCuLUwUK84uEnUTt8KsoGKGmfnSxB9R3sCQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
EFS according to BCL-2 expression levels in primary leukemic cells in immunophenotypically distinct patient subsets. The cumulative proportions of T-lineage ALL (shown in [A]) and B-lineage ALL (shown in [B]) patients surviving event-free are shown according to levels of BCL-2 expression on leukemic cells. Patients were divided into two groups: BCL-2 level ≥ median and BCL-2 level < median. BCL-2 level showed no prognostic effect on EFS in either subset.
